Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
111 hedge funds and large institutions have $21.1M invested in Vaxart in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 19 increasing their positions, 36 reducing their positions, and 23 closing their positions.
302% more call options, than puts
Call options by funds: $189K | Put options by funds: $47K
13% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 23
2% more funds holding
Funds holding: 109 → 111 (+2)
3.79% less ownership
Funds ownership: 25.13% → 21.34% (-3.8%)
18% less capital invested
Capital invested by funds: $25.8M → $21.1M (-$4.64M)
47% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 36
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
+$6.59M |
| 2 |
Millennium Management
New York
|
+$1.92M |
| 3 |
Renaissance Technologies
New York
|
+$684K |
| 4 |
RCMU
Rokos Capital Management (UK)
London,
United Kingdom
|
+$465K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$317K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$6.4M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.98M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.68M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.02M |
| 5 |
Two Sigma Investments
New York
|
-$917K |
VXRT Hedge Fund Activity: Q2 2023 in Review
111 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2023, worth a combined $21.1M — down 18% from $25.8M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new VXRT positions and 23 closed out — a net gain of 3 holders — while 19 added to existing stakes and 36 trimmed.
The largest buyer was Cantor Fitzgerald, opening a new position worth an estimated $6.59M. The largest seller was BlackRock, cutting an estimated $6.4M.
- 111 institutional investors held Vaxart (VXRT) as of Q2 2023, up from 109 in Q1 2023.
- Funds reported $21.1M of Vaxart stock for Q2 2023, down 18% quarter-over-quarter.
- 26 funds opened new Vaxart positions in Q2 2023 and 23 closed out, a net change of +3 holders.
- The largest Vaxart buyer in Q2 2023 was Cantor Fitzgerald, an estimated $6.59M added.
- The largest Vaxart seller in Q2 2023 was BlackRock, an estimated $6.4M sold.
Based on aggregated 13F filings for Q2 2023.